Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations - PubMed (original) (raw)
Affiliations
- PMID: 8658215
Review
Invasion and metastases in gastric cancer: in vitro and in vivo models with clinical correlations
G K Schwartz. Semin Oncol. 1996 Jun.
Abstract
The major obstacle towards improved survival from gastric cancer is in the development of metastatic disease. Techniques in cellular and molecular biology have now advanced to the point to allow an examination of specific biomolecules in processes related to gastric cancer cell invasion through the basement membrane of blood vessels or lymphatics (eg, the first step in developing metastatic disease). Identification of such biomolecules in primary gastric cancer has been enhanced by the establishment of primary human gastric cancer cell lines. These cell lines, named SK-GT for Sloan-Kettering gastric tumor, have provided the basis for a detailed analysis of the invasive phenotype of gastric cancer cells and has resulted in the identification of potentially important prognostic biomarkers. These molecular studies have revealed that in gastric cancer cells there exists a series of integrated biomolecules that are intimately involved in processes related to tumor cell invasion. Included among these are proteins associated with attachment to the basement membrane (ie, laminin receptor) as well as with proteolysis of the basement membrane (ie, matrix metalloproteinase-2, MMP-2). These factors, as well as others, have been clinically evaluated for their prognostic significance in patients with resected, primary gastric cancer. These clinical studies indicate that overexpression of factors associated with the invasion of gastric cancer cells through the basement membrane, including E-cadherin, MMP-2, plasminogen activator inhibitor-1 (PAI-1), and tissue inhibitor metalloproteinase-2 (TIMP-2), can be predictive of tumor recurrence and overall survival in patients with this disease.
Similar articles
- Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW, Karashima T, Perrotte P, Inoue K, Kim SJ, Izawa J, Kedar D, McConkey DJ, Millikan R, Sweeney P, Yoshikawa C, Shuin T, Dinney CP. Slaton JW, et al. Clin Cancer Res. 2001 Sep;7(9):2840-53. Clin Cancer Res. 2001. PMID: 11555602 - Secreted LOXL2 is a novel therapeutic target that promotes gastric cancer metastasis via the Src/FAK pathway.
Peng L, Ran YL, Hu H, Yu L, Liu Q, Zhou Z, Sun YM, Sun LC, Pan J, Sun LX, Zhao P, Yang ZH. Peng L, et al. Carcinogenesis. 2009 Oct;30(10):1660-9. doi: 10.1093/carcin/bgp178. Epub 2009 Jul 22. Carcinogenesis. 2009. PMID: 19625348 - p75 neurotrophin receptor inhibits invasion and metastasis of gastric cancer.
Jin H, Pan Y, He L, Zhai H, Li X, Zhao L, Sun L, Liu J, Hong L, Song J, Xie H, Gao J, Han S, Li Y, Fan D. Jin H, et al. Mol Cancer Res. 2007 May;5(5):423-33. doi: 10.1158/1541-7786.MCR-06-0407. Mol Cancer Res. 2007. PMID: 17510309 - Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy.
Schmitt M, Harbeck N, Thomssen C, Wilhelm O, Magdolen V, Reuning U, Ulm K, Höfler H, Jänicke F, Graeff H. Schmitt M, et al. Thromb Haemost. 1997 Jul;78(1):285-96. Thromb Haemost. 1997. PMID: 9198168 Review. - Molecular inhibition of cancer cell invasion and metastasis.
Castronovo V, Stetler-Stevenson WG, Sobel ME, Liotta LA. Castronovo V, et al. Princess Takamatsu Symp. 1991;22:319-37. Princess Takamatsu Symp. 1991. PMID: 1844249 Review.
Cited by
- Association of endothelial nitric oxide synthase gene T-786C promoter polymorphism with gastric cancer.
Krishnaveni D, Amar Chand B, Shravan Kumar P, Uma Devi M, Ramanna M, Jyothy A, Pratibha N, Balakrishna N, Venkateshwari A. Krishnaveni D, et al. World J Gastrointest Oncol. 2015 Jul 15;7(7):87-94. doi: 10.4251/wjgo.v7.i7.87. World J Gastrointest Oncol. 2015. PMID: 26191352 Free PMC article. - Differential expression of aristaless-like homeobox 4: a potential marker for gastric adenocarcinoma.
Ghasemvand F, Nezafat N, Hesami Tackallou S, Momenzadeh D, Rahmanzadeh S. Ghasemvand F, et al. Gastroenterol Hepatol Bed Bench. 2016 Fall;9(4):286-294. Gastroenterol Hepatol Bed Bench. 2016. PMID: 27895854 Free PMC article. - Gastric adenocarcinoma: review and considerations for future directions.
Dicken BJ, Bigam DL, Cass C, Mackey JR, Joy AA, Hamilton SM. Dicken BJ, et al. Ann Surg. 2005 Jan;241(1):27-39. doi: 10.1097/01.sla.0000149300.28588.23. Ann Surg. 2005. PMID: 15621988 Free PMC article. Review. - Changes of histology and expression of MMP-2 and nm23-H1 in primary and metastatic gastric cancer.
Wang LB, Jiang ZN, Fan MY, Xu CY, Chen WJ, Shen JG. Wang LB, et al. World J Gastroenterol. 2008 Mar 14;14(10):1612-6. doi: 10.3748/wjg.14.1612. World J Gastroenterol. 2008. PMID: 18330957 Free PMC article. - Recent advances in endoscopic management of gastric neoplasms.
Cheema HI, Tharian B, Inamdar S, Garcia-Saenz-de-Sicilia M, Cengiz C. Cheema HI, et al. World J Gastrointest Endosc. 2023 May 16;15(5):319-337. doi: 10.4253/wjge.v15.i5.319. World J Gastrointest Endosc. 2023. PMID: 37274561 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous